Back
Pliant Therapeutics Stock Price Chart
Sponsored
Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
100
PLRX
Pliant Therapeutics
Last Price:
34.47
Seasonality Move:
-10.04%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing selling pressure, which indicates risk of future bearish movement.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.47 | Buy |
| 20-day SMA: | 23.96 | Buy |
| 50-day SMA: | 20.98 | Buy |
| 200-day SMA: | 16.65 | Buy |
| 8-day EMA: | 30.82 | Buy |
| 20-day EMA: | 26.01 | Buy |
| 50-day EMA: | 22.75 | Buy |
| 200-day EMA: | 18.88 | Buy |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.82 | Buy |
| Relative Strength Index (14 RSI): | 81.21 | Buy |
| Chaikin Money Flow: | -1038779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.19 - 28.67) | Buy |
| Bollinger Bands (100): | (18.17 - 25.17) | Buy |
Pliant Therapeutics Technical Analysis
| Jan-13 | Jan-17 | Jan-18 | Jan-19 | Jan-20 | Jan-23 | Jan-24 | Jan-25 | Jan-26 | Jan-27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 34.87 while PLRX 8-day simple moving average is 29.47, which is a Buy signal.
- The stock price of PLRX is 34.87 while Pliant Therapeutics 20-day SMA is 23.96, which makes it a Buy.
- Pliant Therapeutics 50-day simple moving average is 20.98 while PLRX share price is 34.87, making it a Buy technically.
- PLRX stock price is 34.87 and Pliant Therapeutics 200-day simple moving average is 16.65, creating a Buy signal.
PLRX Technical Analysis vs Fundamental Analysis
Buy
100
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Buy
The current Pliant Therapeutics [PLRX] share price is $34.87. The Score for PLRX is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
1.7B
Price in USD:
34.87
Share Volume:
1.04M
Pliant Therapeutics 52-Week Range
52-Week High:
36.64
52-Week Low:
3.97
Buy
100
Pliant Therapeutics (PLRX)
is a Buy
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 34.87 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is not overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 34.87 while PLRX 8-day exponential moving average is 30.82, which is a Buy signal.
- The stock price of PLRX is 34.87 while Pliant Therapeutics 20-day EMA is 26.01, which makes it a Buy.
- Pliant Therapeutics 50-day exponential moving average is 22.75 while PLRX share price is 34.87, making it a Buy technically.
- PLRX stock price is 34.87 and Pliant Therapeutics 200-day simple moving average is 18.88, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is 3.82, suggesting Pliant Therapeutics is a Buy
- Pliant Therapeutics Relative Strength Index (RSI) is 81.21, which suggest Pliant Therapeutics is overbought
- The Bollinger Bands (25) for Pliant Therapeutics is (17.19 - 28.67), which suggest Pliant Therapeutics is a Buy
- The Bollinger Bands (100) for Pliant Therapeutics is (18.17 - 25.17), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.